Ruoslahti E - Search Results

1

Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors.

Briknarová K, Akerman ME, Hoyt DW, Ruoslahti E, Ely KR. Briknarová K, et al. Among authors: ruoslahti e. J Mol Biol. 2003 Sep 5;332(1):205-15. doi: 10.1016/s0022-2836(03)00890-8. J Mol Biol. 2003. PMID: 12946358

2

Crystal structure of the tenth type III cell adhesion module of human fibronectin.

Dickinson CD, Veerapandian B, Dai XP, Hamlin RC, Xuong NH, Ruoslahti E, Ely KR. Dickinson CD, et al. Among authors: ruoslahti e. J Mol Biol. 1994 Mar 4;236(4):1079-92. doi: 10.1016/0022-2836(94)90013-2. J Mol Biol. 1994. PMID: 8120888

3

Crystals of the cell-binding module of fibronectin obtained from a series of recombinant fragments differing in length.

Dickinson CD, Gay DA, Parello J, Ruoslahti E, Ely KR. Dickinson CD, et al. Among authors: ruoslahti e. J Mol Biol. 1994 Apr 22;238(1):123-7. doi: 10.1006/jmbi.1994.1272. J Mol Biol. 1994. PMID: 8145252

4

Conformational flexibility and crystallization of tandemly linked type III modules of human fibronectin.

Lombardo A, Wang Y, Ni CZ, Dai X, Dickinson CD, Kodandapani R, Chiang S, White CA, Pio F, Xuong NH, Hamlin RC, Ruoslahti E, Ely KR. Lombardo A, et al. Among authors: ruoslahti e. Protein Sci. 1996 Sep;5(9):1934-8. doi: 10.1002/pro.5560050922. Protein Sci. 1996. PMID: 8880920 Free PMC article.

5

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.

Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Christian S, et al. Among authors: ruoslahti e. J Cell Biol. 2003 Nov 24;163(4):871-8. doi: 10.1083/jcb.200304132. J Cell Biol. 2003. PMID: 14638862 Free PMC article.

6

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature.

Akerman ME, Pilch J, Peters D, Ruoslahti E. Akerman ME, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2040-5. doi: 10.1073/pnas.0409844102. Epub 2005 Feb 1. Proc Natl Acad Sci U S A. 2005. PMID: 15687502 Free PMC article.

7

Nanocrystal targeting in vivo.

Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Akerman ME, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12617-21. doi: 10.1073/pnas.152463399. Epub 2002 Sep 16. Proc Natl Acad Sci U S A. 2002. PMID: 12235356 Free PMC article.

8

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, Hoffman RM, Ruoslahti E. Laakkonen P, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6. doi: 10.1073/pnas.0403317101. Epub 2004 Jun 14. Proc Natl Acad Sci U S A. 2004. PMID: 15197262 Free PMC article.

9

The anti-angiogenic peptide anginex disrupts the cell membrane.

Pilch J, Franzin CM, Knowles LM, Ferrer FJ, Marassi FM, Ruoslahti E. Pilch J, et al. Among authors: ruoslahti e. J Mol Biol. 2006 Mar 3;356(4):876-85. doi: 10.1016/j.jmb.2005.12.006. Epub 2005 Dec 20. J Mol Biol. 2006. PMID: 16403516 Free PMC article.

10

Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity.

Yi M, Sakai T, Fassler R, Ruoslahti E. Yi M, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11435-8. doi: 10.1073/pnas.1635112100. Epub 2003 Sep 17. Proc Natl Acad Sci U S A. 2003. PMID: 13679585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page